While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...
Healthcare will always be around. But tech is just beginning. Why not mix them both together? The post This Healthcare Stock ...
Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...
These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...
European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...
HCA Healthcare’s board has authorized an additional share repurchase program for up to $10 billion. HCA declared a ...
Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.
For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...
Cyclerion Therapeutics CYCN stock moved upwards by 31.9% to $3.35 during Friday's pre-market session. The company's market cap stands at $9.0 million. LakeShore Biopharma LSB stock moved upwards by 21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback